Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Can Intermittent Fasting Help You Lose Weight And Provide Other Health Benefits?

While it has been widely promoted as a weight loss strategy, research suggests that intermittent fasting may have broader benefits for overall health and well-being. A study published in the New England Journal of Medicine found that Intermittent Fasting can help lower blood pressure, improve insulin sensitivity, and reduce the risk of chronic diseases such…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

While it has been widely promoted as a weight loss strategy, research suggests that intermittent fasting may have broader benefits for overall health and well-being. A study published in the New England Journal of Medicine found that Intermittent Fasting can help lower blood pressure, improve insulin sensitivity, and reduce the risk of chronic diseases such as diabetes and heart disease.

Another study in the journal Cell Metabolism found that Intermittent Fasting can increase the production of a protein called brain-derived neurotrophic factor (BDNF), which is essential for the growth and maintenance of neurons in the brain.

Despite these promising findings, new research found that intermittent fasting may not be as beneficial for weight loss as previously thought while another study found that that it does not bring the same health benefits as other weight loss programs.

These new findings leave lots of questions unanswered. Does intermittent fasting help with weight loss and provide other health benefits or is it just another fad diet targeted to those who are looking to lose weight? Kimberly Gomer, director of nutrition at Body Beautiful Miami, is a leading nutritional expert in weight loss and medical nutrition for over 2 decades. She brings her years of experience to the discussion and offers her in-depth analysis of this dietary strategy.

Kim’s Thoughts:

I love this article on intermittent fasting because it brings to light an unknown idea for a lot of people. I do believe from the science, looking at the science, that there is benefit to time-restricted eating. So, you’re fasting for a certain amount of time and then you’re eating. The idea that immune autophagy maintaining muscle mass is a possibility with fasting.

But the exciting part for me as a nutritionist is the stability of blood sugar. Because high insulin levels, high blood sugars are a huge problem in the United States—we are looking at one in three people with prediabetes. We are looking at one in 10 people with diabetes, and we are looking at one in five people who don’t even know they have it.

So, this idea that we can lower insulin levels and we can stabilize blood sugar and do it through an intermittent fasting lifestyle, is amazing. And part of the science behind it is that when you are not eating, be it sleeping or just not eating, your insulin is very low. It’s the lowest when you’re not eating so allowing for a time that you are not eating in your day to be extended and eating only in a certain window, there are a lot of health benefits.

The problem that I see with some of these articles and understanding how they would apply to you as an individual is the fasting times are all over the place. Are you fasting for 18 hours a day? Are you fasting for 16 hours a day? Are you fasting for 12 hours a day?

Is your eating window very short? One to three hours or long eight hours. So, this idea of what is the best fasting and eating window is still not clear in some of the research, and more important in my mind, yes, intermittent fasting is a great tool. I use it in my private practice as a dietician with a lot of success.

But one thing that has to come with it is what are you eating? We live in a world of obesogenic food, highly processed, unhealthy food. So, some of my clients actually think, some people think well I can fast for 20 hours and for four hours I can go and eat fast food and eat junk, and I’m going to be healthy and thin. Not true.

So, I love intermittent fasting, I think we need more and more research about it. I think people need to be clear about what will work for them, how the tool can work for them as an individual, and more importantly, be clear about what they’re actually eating during their window. Again, I’m going to say I think that intermittent fasting is an awesome tool.

I’m so happy to see research being published. More research needs to be done and I think it can be very useful for a lot of people. Thank you.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512